TATVA CHINTAN PHARMA CHEM LIMITED
Tatva Chintan was incorporated in the year 1996. Tatva Chintan is a speciality chemicals manufacturing company engaged in the manufacture of a diverse portfolio of structure-directing agents (“SDAs”), phase transfer catalysts (“PTCs”), electrolyte salts for super capacitor batteries and pharmaceutical and agrochemical intermediates and other speciality chemicals (“PASC”). The company is the largest and only commercial manufacturer of SDAs for zeolites in India. Tatva Chintan is promoted by Chintan Shah, Ajay Patel and Shekhar Somani.The company is one of the leading global producers of an entire range of PTCs in India and one of the key producers across the globe. Tatva Chintan serves its customers across various industries, including the automotive, petroleum, pharmaceutical, agrochemicals, paints and coatings, dyes and pigments, personal care and flavour and fragrances industries. The company also export their products to over 25 countries, including the USA, China, Germany, Japan, South Africa, and the UK.For FY 21, the company had total assets of Rs 3,148.03 million and a Revenue of Rs. 3,062.92 million. Both assets & revenue showed an increase from the past two financial years, which is a good sign. The opening IPO date is 16th July 2021 till 20th July 2021, with the IPO price of Rs 1073 to Rs 1083 per equity share. The issue size of the IPO is supposed to be Rs 500.00 Cr. Considering the domain of the company & future prospects of this sector, IPO stands out to be a good investment option.
